Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artara Therapeutics Inc (NQ: TARA )

3.010 -0.030 (-0.99%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 268,422
Open 3.060
Bid (Size) 2.950 (100)
Ask (Size) 3.000 (2)
Prev. Close 3.040
Today's Range 2.910 - 3.251
52wk Range 1.270 - 5.240
Shares Outstanding 11,235,731
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TARA Stock Earnings: Protara Therapeutics Beats EPS for Q2 2024
TARA stock results show that Protara Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
TARA Stock Earnings: Protara Therapeutics Misses EPS for Q1 2024
TARA stock results show that Protara Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+43.33%
+43.33%
1 Month
+28.63%
+28.63%
3 Month
+50.50%
+50.50%
6 Month
+7.12%
+7.12%
1 Year
+107.59%
+107.59%

More News

Read More
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Recap: Protara Therapeutics Q1 Earnings
Via Benzinga
Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
Via Benzinga
Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations
Via Benzinga
3 Stocks That Could Help You Retire on a Private Island
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Protara Therapeutics: Q3 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Recap: Protara Therapeutics Q4 Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.